165 related articles for article (PubMed ID: 25934452)
1. Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer.
Vong LB; Yoshitomi T; Matsui H; Nagasaki Y
Biomaterials; 2015 Jul; 55():54-63. PubMed ID: 25934452
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
Yoshitomi T; Nagasaki Y
Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
[TBL] [Abstract][Full Text] [Related]
3. Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles.
Vong LB; Nagasaki Y
Mol Pharm; 2016 Feb; 13(2):449-55. PubMed ID: 26605906
[TBL] [Abstract][Full Text] [Related]
4. Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy.
Vong LB; Mo J; Abrahamsson B; Nagasaki Y
J Control Release; 2015 Jul; 210():19-25. PubMed ID: 25998050
[TBL] [Abstract][Full Text] [Related]
5. Newly Designed Silica-Containing Redox Nanoparticles for Oral Delivery of Novel TOP2 Catalytic Inhibitor for Treating Colon Cancer.
Vong LB; Kimura S; Nagasaki Y
Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28736844
[TBL] [Abstract][Full Text] [Related]
6. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice.
Vong LB; Tomita T; Yoshitomi T; Matsui H; Nagasaki Y
Gastroenterology; 2012 Oct; 143(4):1027-36.e3. PubMed ID: 22771506
[TBL] [Abstract][Full Text] [Related]
7. Silica-installed redox nanoparticles for novel oral nanotherapeutics - improvement in intestinal delivery with anti-inflammatory effects.
Hossain MA; Yamashita M; Vong LB; Ikeda Y; Nagasaki Y
J Drug Target; 2014 Aug; 22(7):638-47. PubMed ID: 24955616
[TBL] [Abstract][Full Text] [Related]
8. Oral nanotherapeutics: effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced colitis.
Vong LB; Yoshitomi T; Morikawa K; Saito S; Matsui H; Nagasaki Y
J Gastroenterol; 2014 May; 49(5):806-13. PubMed ID: 23715850
[TBL] [Abstract][Full Text] [Related]
9. Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.
Yoshitomi T; Ozaki Y; Thangavel S; Nagasaki Y
J Control Release; 2013 Nov; 172(1):137-143. PubMed ID: 23958903
[TBL] [Abstract][Full Text] [Related]
10. Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
Biomaterials; 2016 Aug; 99():109-23. PubMed ID: 27235996
[TBL] [Abstract][Full Text] [Related]
11. Suppression of NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
Sha S; Vong LB; Chonpathompikunlert P; Yoshitomi T; Matsui H; Nagasaki Y
Biomaterials; 2013 Nov; 34(33):8393-400. PubMed ID: 23896000
[TBL] [Abstract][Full Text] [Related]
12. Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice.
Feliciano CP; Tsuboi K; Suzuki K; Kimura H; Nagasaki Y
Biomaterials; 2017 Jun; 129():68-82. PubMed ID: 28324866
[TBL] [Abstract][Full Text] [Related]
13. Oral nanotherapeutics: Redox nanoparticles attenuate ultraviolet B radiation-induced skin inflammatory disorders in Kud:Hr- hairless mice.
Feliciano CP; Nagasaki Y
Biomaterials; 2017 Oct; 142():162-170. PubMed ID: 28743058
[TBL] [Abstract][Full Text] [Related]
14. A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatment.
Nguyen-Trinh QN; Trinh KXT; Trinh NT; Vo VT; Li N; Nagasaki Y; Vong LB
Acta Biomater; 2022 Apr; 143():459-470. PubMed ID: 35235866
[TBL] [Abstract][Full Text] [Related]
15. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles.
Yoshitomi T; Hirayama A; Nagasaki Y
Biomaterials; 2011 Nov; 32(31):8021-8. PubMed ID: 21816462
[TBL] [Abstract][Full Text] [Related]
16. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
17. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
Han W; Xie B; Li Y; Shi L; Wan J; Chen X; Wang H
Theranostics; 2019; 9(24):7458-7473. PubMed ID: 31695780
[No Abstract] [Full Text] [Related]
18. Indomethacin-loaded redox nanoparticles improve oral bioavailability of indomethacin and suppress its small intestinal inflammation.
Yoshitomi T; Sha S; Vong LB; Chonpathompikunlert P; Matsui H; Nagasaki Y
Ther Deliv; 2014 Jan; 5(1):29-38. PubMed ID: 24341815
[TBL] [Abstract][Full Text] [Related]
19. Novel neuroprotection using antioxidant nanoparticles in a mouse model of head trauma.
Takahashi T; Marushima A; Nagasaki Y; Hirayama A; Muroi A; Puentes S; Mujagic A; Ishikawa E; Matsumura A
J Trauma Acute Care Surg; 2020 May; 88(5):677-685. PubMed ID: 32039974
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Toxicity and Antioxidant Activity of Redox Nanoparticles in Zebrafish (Danio rerio) Embryos.
Vong LB; Kobayashi M; Nagasaki Y
Mol Pharm; 2016 Sep; 13(9):3091-7. PubMed ID: 27186993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
